These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 19837518

  • 1. Acute HPA axis response to naltrexone differs in female vs. male smokers.
    Roche DJ, Childs E, Epstein AM, King AC.
    Psychoneuroendocrinology; 2010 May; 35(4):596-606. PubMed ID: 19837518
    [Abstract] [Full Text] [Related]

  • 2. Hypothalamic-pituitary-adrenocortical (HPA) axis response and biotransformation of oral naltrexone: preliminary examination of relationship to family history of alcoholism.
    King AC, Schluger J, Gunduz M, Borg L, Perret G, Ho A, Kreek MJ.
    Neuropsychopharmacology; 2002 Jun; 26(6):778-88. PubMed ID: 12007748
    [Abstract] [Full Text] [Related]

  • 3. Stimulation of the hypothalamic-pituitary-adrenal axis with the opioid antagonist nalmefene.
    Geer EB, Landman RE, Wardlaw SL, Conwell IM, Freda PU.
    Pituitary; 2005 Jun; 8(2):115-22. PubMed ID: 16379031
    [Abstract] [Full Text] [Related]

  • 4. Blunted opiate modulation of hypothalamic-pituitary-adrenocortical activity in men and women who smoke.
    al'Absi M, Wittmers LE, Hatsukami D, Westra R.
    Psychosom Med; 2008 Oct; 70(8):928-35. PubMed ID: 18799426
    [Abstract] [Full Text] [Related]

  • 5. Effect of opioid receptor antagonists on hypothalamic-pituitary-adrenal activity in rhesus monkeys.
    Williams KL, Ko MC, Rice KC, Woods JH.
    Psychoneuroendocrinology; 2003 May; 28(4):513-28. PubMed ID: 12689609
    [Abstract] [Full Text] [Related]

  • 6. Hypothalamic-pituitary-adrenocortical axis activity: a target of pharmacological anticraving treatment?
    Kiefer F, Jahn H, Otte C, Naber D, Wiedemann K.
    Biol Psychiatry; 2006 Jul 01; 60(1):74-6. PubMed ID: 16483549
    [Abstract] [Full Text] [Related]

  • 7. Hypothalamic-pituitary-adrenal axis response to oral naltrexone in alcoholics during early withdrawal.
    Besirli A, Eşel E, Özsoy S, Turan T.
    Pharmacopsychiatry; 2014 Jul 01; 47(4-5):151-5. PubMed ID: 24936803
    [Abstract] [Full Text] [Related]

  • 8. Hypothalamic-pituitary-adrenal axis response to acute psychosocial stress: Effects of biological sex and circulating sex hormones.
    Stephens MA, Mahon PB, McCaul ME, Wand GS.
    Psychoneuroendocrinology; 2016 Apr 01; 66():47-55. PubMed ID: 26773400
    [Abstract] [Full Text] [Related]

  • 9. Naltrexone effects on cortisol secretion in women and men in relation to a family history of alcoholism: studies from the Oklahoma Family Health Patterns Project.
    Lovallo WR, King AC, Farag NH, Sorocco KH, Cohoon AJ, Vincent AS.
    Psychoneuroendocrinology; 2012 Dec 01; 37(12):1922-8. PubMed ID: 22575355
    [Abstract] [Full Text] [Related]

  • 10. Luteal phase sertraline treatment of premenstrual dysphoric disorder (PMDD): Effects on markers of hypothalamic pituitary adrenal (HPA) axis activation and inflammation.
    Barone JC, Ho A, Osborne LM, Eisenlohr-Moul TA, Morrow AL, Payne JL, Epperson CN, Hantsoo L.
    Psychoneuroendocrinology; 2024 Nov 01; 169():107145. PubMed ID: 39096755
    [Abstract] [Full Text] [Related]

  • 11. Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitary-adrenal axis.
    Kirschbaum C, Kudielka BM, Gaab J, Schommer NC, Hellhammer DH.
    Psychosom Med; 1999 Nov 01; 61(2):154-62. PubMed ID: 10204967
    [Abstract] [Full Text] [Related]

  • 12. The relationship between naloxone-induced cortisol and delta opioid receptor availability in mesolimbic structures is disrupted in alcohol-dependent subjects.
    Wand GS, Weerts EM, Kuwabara H, Wong DF, Xu X, McCaul ME.
    Addict Biol; 2013 Jan 01; 18(1):181-92. PubMed ID: 22264217
    [Abstract] [Full Text] [Related]

  • 13. A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal man.
    Inder WJ, Ellis MJ, Evans MJ, Donald RA.
    Clin Endocrinol (Oxf); 1995 Oct 01; 43(4):425-31. PubMed ID: 7586616
    [Abstract] [Full Text] [Related]

  • 14. Acute effects of intravenous heroin on the hypothalamic-pituitary-adrenal axis response: a controlled trial.
    Walter M, Gerber H, Kuhl HC, Schmid O, Joechle W, Lanz C, Brenneisen R, Schächinger H, Riecher-Rössler A, Wiesbeck GA, Borgwardt SJ.
    J Clin Psychopharmacol; 2013 Apr 01; 33(2):193-8. PubMed ID: 23422375
    [Abstract] [Full Text] [Related]

  • 15. Naltrexone alters alcohol self-administration behaviors and hypothalamic-pituitary-adrenal axis activity in a sex-dependent manner in rats.
    Nieto SJ, Quave CB, Kosten TA.
    Pharmacol Biochem Behav; 2018 Apr 01; 167():50-59. PubMed ID: 29486222
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Variable dose naltrexone-induced hypothalamic-pituitary-adrenal stimulation in abstinent alcoholics: a preliminary study.
    Farren CK, O'Malley S, Grebski G, Maniar S, Porter M, Kreek MJ.
    Alcohol Clin Exp Res; 1999 Mar 01; 23(3):502-8. PubMed ID: 10195825
    [Abstract] [Full Text] [Related]

  • 19. Clinical safety and hypothalamic-pituitary-adrenal axis effects of the arginine vasopressin type 1B receptor antagonist ABT-436.
    Katz DA, Liu W, Locke C, Dutta S, Tracy KA.
    Psychopharmacology (Berl); 2016 Jan 01; 233(1):71-81. PubMed ID: 26407603
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.